Review


DOI :https://doi.org/10.18017/iuitfd.279884   IUP :https://doi.org/10.18017/iuitfd.279884    Full Text (PDF)

YAYGIN DEĞİŞKEN İMMÜN YETERSİZLİK

Orkide KutluHasan EruzunTufan Tükek

Yaygın değişken immün yetersizlik, erişkinlerde görülen en sık primer immun yetersizlik durumudur. Bozulmuş B hücre diferansiyasyonu sebebiyle immunglobulinlerin sentezinde yetersizlik ile karakterizedir. Yaygın değişken immun yetersizlik tanısı, tekrarlayan bakteriyel infeksiyonlar gözlenen hastalarda kronik akciğer hastalığı, gastrointestinal sistem ve karaciğer hastalıkları, çeşitli organlarda granülomatöz hastalıklar, otoimmünite, lenfoid hiperplazi, splenomegali veya malignitelerin incelenmesi sonucunda konabilir. Serum IgG konsantrasyonu belirgin düşük olup IgA ve/veya IgM konsantrasyonunda da düşüklük saptanır. Tedavide intravenöz immünglobulin verilmesi ilk seçenektir. İmmunglobulin tedavisi sayesinde, başta rekürren infeksiyonlar olmak üzere pulmoner hasar ve otoimmün hastalıklar gibi eşlik eden komplikasyonlar da büyük ölçüde kontrol altına alınmış olur. İmmünglobulin tedavisi ile yaygın değişken immün yetersizlikli hastaların akut bakteriyel infeksiyonlardan kaybedilmesi önlenebildiği için başlıca ölüm sebebi kronik akciğer hastalıkları veya malignitelerdir.

DOI :https://doi.org/10.18017/iuitfd.279884   IUP :https://doi.org/10.18017/iuitfd.279884    Full Text (PDF)

COMMON VARIABLE IMMUNODEFICIENCY

Orkide KutluHasan EruzunTufan Tükek

Common variable immunodeficiency is the most commonly seen primary immune deficiency condition in adults, characterized by impaired B cell differentiation. The patient is diagnosed with common variable immunodeficiency by recurrent bacterial infections usually accompanied by chronic lung diseases, gastrointestinal/liver diseases, granulomatous diseases, autoimmunity, lymphoid hyperplasia, splenomegaly or malignancies. Serum IgG concentration is significantly low along with low IgA and/or IgM concentrations. Intravenous immunoglobulin (IVIG) is the first choice of treatment. Immunoglobulin treatment ameliorates recurrent infections and associated complications such as autoimmune diseases and pulmonary injury. The main cause of death in patients with common variable immunodeficiency is chronic lung diseases or malignancies, because acute bacterial infections is usually prevented by IVIG therapy


PDF View

References

  • 1. Conley ME, Notarangelo LD, Etzioni A. Diagnostic criteria for primaryimmunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol 1999;93:190. google scholar
  • 2. Chapel H, Cunningham-Rundles C. Update in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditions. Br J Haematol 2009;145:709. google scholar
  • 3. Hammarström L, Vorechovsky I, Webster D. Selective IgA deficiency (SIgAD) and common variable immunodeficiency (CVID). Clin Exp Immunol 2000;120:225. google scholar
  • 4. Cunningham-Rundles C, Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol 1999;92:34. google scholar
  • 5. Webster ADB. Common Variable Immunodeficiency. Immunol Allergy Clin North Am 2001;21:1. google scholar
  • 6. Gathmann B, Mahlaoui N, CEREDIH, et al. Clinical picture and treatment of 2212 patients with common variable immunodeficiency. J Allergy Clin Immunol 2014;134:116. google scholar
  • 7. Resnick ES, Moshier EL, Godbold JH, Cunningham-Rundles C. Morbidity and mortality in common variable immune deficiency over 4 decades. Blood 2012;119:1650. google scholar
  • 8. Chapel H, Lucas M, Lee M, et al. Common variable immunodeficiency disorders: division into distinct clinical phenotypes. Blood 2008;112:277. google scholar
  • 9. Glaum MC, Levinson AI. Asymptomatic longstanding panhypogammaglobulinemia with impaired antibody responses. Ann Allergy Asthma Immunol 2008;100:396. google scholar
  • 10. Quinti I, Soresina A, Spadaro G, et al. Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency. J Clin Immunol 2007;27:308. google scholar
  • 11. Notarangelo LD, Fischer A, et al. International Union of Immunological Societies Expert Committee on Primary Immunodeficiencies, Primary immunodeficiencies: 2009 update. J Allergy Clin Immunol 2009;124:1161. google scholar
  • 12. Wehr C, Kivioja T, Schmitt C, et al. The EUROclass trial: defining subgroups in common variable immunodeficiency. Blood 2008;111:77 google scholar
  • 13. Orange JS, Glessner JT, Resnick E, et al. Genomewide association identifies diverse causes of common variable immunodeficiency. J Allergy Clin Immunol 2011;127:1360. google scholar
  • 14. Slavin RG, Spector SL, Bernstein IL, et al. The diagnosis and management of sinusitis: a practice parameter update. J Allergy Clin Immunol 2005;116:13. google scholar
  • 15.Roifman CM, Levison H, Gelfand EW. High-dose versus low-dose intravenous immunoglobulin in hypogammaglobulinaemia and chronic lung disease. Lancet 1987;1:1075. 16.Busse PJ, Farzan S, Cunningham-Rundles C. Pulmonary complications of common variable immunodeficiency. Ann Allergy Asthma Immunol 2007;98:1. google scholar
  • 17. Wang J, Cunningham-Rundles C. Treatment and outcome of autoimmune hematologic disease in common variable immunodeficiency (CVID). J Autoimmun 2005;25:57. google scholar
  • 18. Woodward JM, Gkrania-Klotsas E, Cordero-Ng AY, et al. The role of chronic norovirus infection in the enteropathy associated with common variable immunodeficiency. Am J Gastroenterol 2015;110:320. google scholar
  • 19. Franz A, Webster AD, Furr PM, Taylor-Robinson D. Mycoplasmal arthritis in patients with primary immunoglobulin deficiency: clinical features and outcome in 18 patients. Br J Rheumatol 1997;36:661. google scholar
  • 20. Park JH, Levinson AI. Granulomatous-lymphocytic interstitial lung disease (GLILD) in common variable immunodeficiency (CVID). Clin Immunol 2010;134:97. google scholar
  • 21. Wheat WH, Cool CD, Morimoto Y, et al. Possible role of human herpesvirus 8 in the lymphoproliferative disorders in common variable immunodeficiency. J Exp Med 2005;202:479. google scholar
  • 22. Agarwal S, Mayer L. Pathogenesis and treatment of gastrointestinal disease in antibody deficiency syndromes. J Allergy Clin Immunol 2009; 124:658. google scholar
  • 23. Maarschalk-Ellerbroek LJ, Oldenburg B, Mombers IM, et al. Outcome of screening endoscopy in common variable immunodeficiency disorder and Xlinked agammaglobulinemia. Endoscopy 2013;45:320. google scholar
  • 24.Bayraktar Y, Ersoy O, Sokmensuer C. The findings of capsule endoscopy in patients with common variable immunodeficiency syndrome. Hepatogastroenterology 2007;54:1034. google scholar
  • 25. Daniels JA, Lederman HM, Maitra A, et al. Gastrointestinal tract pathology in patients with common variable immunodeficiency (CVID): a clinicopathologic study and review. Am J Surg Pathol 2007; 31:1800. google scholar
  • 26. Detková D, de Gracia J, Lopes-da-Silva S, et al. Common variable immunodeficiency: association between memory B cells and lung diseases. Chest 2007;131:1883. google scholar
  • 27. Aslam A, Misbah SA, Talbot K, et al. Vitamin E deficiency induced neurological disease in common variable immunodeficiency: two cases and a review of the literature of vitamin E deficiency. Clin Immunol 2004; 112:24. google scholar
  • 28. Knight AK, Cunningham-Rundles C. Inflammatory and autoimmune complications of common variable immune deficiency. Autoimmun Rev 2006; 5:156. google scholar
  • 29.Boileau J, Mouillot G, Gérard L, et al. Autoimmunity in common variable immunodeficiency: correlation with lymphocyte phenotype in the French DEFI study. J Autoimmun 2011;36:25. google scholar
  • 30. Sève P, Bourdillon L, Sarrot-Reynauld F, et al. Autoimmune hemolytic anemia and common variable immunodeficiency: a case-control study of 18 patients. Medicine (Baltimore) 2008;87:177. google scholar
  • 31. Michel M, Chanet V, Galicier L, et al. Autoimmune thrombocytopenic purpura and common variable immunodeficiency: analysis of 21 cases and review of the literature. Medicine (Baltimore) 2004; 83:254. google scholar
  • 32. Giannouli S, Anagnostou D, Soliotis F, Voulgarelis M. Autoimmune manifestations in common variable immunodeficiency. Clin Rheumatol 2004;23:449. google scholar
  • 33. Sarmiento E, Mora R, Rodríguez-Mahou M, et al. Autoimmune disease in primary antibody deficiencies. Allergol Immunopathol (Madr) 2005;33:69. google scholar
  • 34. Arunachalam M, Sanzo M, Lotti T, et al. Common variable immunodeficiency in vitiligo. G Ital Dermatol Venereol 2010;145:783. google scholar
  • 35. Fernández-Castro M, Mellor-Pita S, Citores MJ, et al. Common variable immunodeficiency in systemic lupus erythematosus. Semin Arthritis Rheum 2007;36:238. google scholar
  • 36. Gobert D, Bussel JB, Cunningham-Rundles C, et al. Efficacy and safety of rituximab in common variable immunodeficiency-associated immune cytopenias: a retrospective multicentre study on 33 patients. Br J Haematol 2011;155:498. google scholar
  • 37.Chapel H, Lucas M, Patel S, et al. Confirmation and improvement of criteria for clinical phenotyping in common variable immunodeficiency disorders in replicate cohorts. J Allergy Clin Immunol 2012; 130:1197. google scholar
  • 38. Artac H, Bozkurt B, Talim B, et al. Sarcoid-like granulomas in common variable immunodeficiency. Rheumatol Int 2009;30:109. google scholar
  • 39.Boursiquot JN, Gérard L, Malphettes M, et al. Granulomatous disease in CVID: retrospective analysis of clinical characteristics and treatment efficacy in a cohort of 59 patients. J Clin Immunol 2013;33:84. google scholar
  • 40. Fasano MB, Sullivan KE, Sarpong SB, et al. Sarcoidosis and common variable immunodeficiency. Report of 8 cases and review of the literature. Medicine (Baltimore) 1996;75:251. google scholar
  • 41. Marashi SM, Raeiszadeh M, Workman S, et al. Inflammation in common variable immunodeficiency is associated with a distinct CD8(+) response to cytomegalovirus. J Allergy Clin Immunol 2011;127:1385. google scholar
  • 42.Chase NM, Verbsky JW, Hintermeyer MK, et al. Use of combination chemotherapy for treatment of granulomatous and lymphocytic interstitial lung disease (GLILD) in patients with common variable immunodeficiency (CVID). J Clin Immunol 2013;33:30. google scholar
  • 43. Lin JH, Liebhaber M, Roberts RL, et al. Etanercept treatment of cutaneous granulomas in common variable immunodeficiency. J Allergy Clin Immunol 2006;117:878. google scholar
  • 44. Thatayatikom A, Thatayatikom S, White AJ. Infliximab treatment for severe granulomatous disease in common variable immunodeficiency: a case report and review of the literature. Ann Allergy Asthma Immunol 2005;95:293. google scholar
  • 45. Agondi RC, Barros MT, Kokron CM, et al. Can patients with common variable immunodeficiency have allergic rhinitis? Am J Rhinol Allergy 2013;27:79. google scholar
  • 46. Agondi RC, Barros MT, Rizzo LV, et al. Allergic asthma in patients with common variable immunodeficiency. Allergy 2010;65:510. google scholar
  • 47. Ward C, Lucas M, Piris J, et al. Abnormal liver function in common variable immunodeficiency disorders due to nodular regenerative hyperplasia. Clin Exp Immunol 2008;153:331. google scholar
  • 48. Malamut G, Ziol M, Suarez F, et al. Nodular regenerative hyperplasia: the main liver disease in patients with primary hypogammaglobulinemia and hepatic abnormalities. J Hepatol 2008;48:74. google scholar
  • 49. Mellemkjaer L, Hammarstrom L, Andersen V, et al. Cancer risk among patients with IgA deficiency or common variable immunodeficiency and their relatives: a combined Danish and Swedish study. Clin Exp Immunol 2002; 130:495. google scholar
  • 50. Dhalla F, da Silva SP, Lucas M, et al. Review of gastric cancer risk factors in patients with common variable immunodeficiency disorders, resulting in a proposal for a surveillance programme. Clin Exp Immunol 2011;165:1. google scholar
  • 51.Cunningham-Rundles C. How I treat common variable immune deficiency. Blood 2010; 116:7. google scholar
  • 52. van de Ven AA, de Jong PA, Terheggen-Lagro SW, et al. High-resolution computed tomography in pediatric common variable immunodeficiency: risks and benefits. Reply. Pediatr Allergy Immunol 2011;22:451. google scholar
  • 53.Cunningham-Rundles C, Siegal FP, Smithwick EM, et al. Efficacy of intravenous immunoglobulin in primary humoral immunodeficiency disease. Ann Intern Med 1984;101:435. google scholar
  • 54. Lucas M, Lee M, Lortan J, et al. Infection outcomes in patients with common variable immunodeficiency disorders: relationship to immunoglobulin therapy over 22 years. J Allergy Clin Immunol 2010;125:1354. google scholar
  • 55. Ellis EF, Henney CS. Adverse reactions following administration of human gamma globulin. J Allergy 1969;43:45. google scholar
  • 56. Eijkhout HW, van Der Meer JW, Kallenberg CG, et al. The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia. A randomized, doubleblind, multicenter crossover trial. Ann Intern Med 2001;135:165. google scholar
  • 57.Busse PJ, Razvi S, Cunningham-Rundles C. Efficacy of intravenous immunoglobulin in the prevention of pneumonia in patients with common variable immunodeficiency. J Allergy Clin Immunol 2002;109:1001. google scholar
  • 58. de Gracia J, Vendrell M, Alvarez A, et al. Immunoglobulin therapy to control lung damage in patients with common variable immunodeficiency. Int Immunopharmacol 2004;4:745. google scholar
  • 59. Kainulainen L, Varpula M, Liippo K, et al. Pulmonary abnormalities in patients with primary hypogammaglobulinemia. J Allergy Clin Immunol 1999;104:1031. google scholar
  • 60. Medical Advisory Committee of the Immune Deficiency Foundation, Shearer WT, Fleisher TA, et al. Recommendations for live viral and bacterial vaccines in immunodeficient patients and their close contacts. J Allergy Clin Immunol 2014; 133:961. google scholar
  • 61. Sewell WA. CVID patients may not respond to influenza immunization. Clin Immunol 2005;114:210; author reply 211. google scholar
  • 62.Cunningham-Rundles C, Bodian C, Ochs HD, et al. Long-term low-dose IL-2 enhances immune function in common variable immunodeficiency. Clin Immunol 2001;100:181. google scholar
  • 63. Wehr C, Gennery AR, Lindemans C, et al. Multicenter experience in hematopoietic stem cell transplantation for serious complications of common variable immunodeficiency. J Allergy Clin Immunol 2015;135:988. google scholar
  • 64. Quinti I, Agostini C, Tabolli S, et al. Malignancies are the major cause of death in patients with adult onset common variable immunodeficiency. Blood 2012;120:1953. google scholar

Citations

Copy and paste a formatted citation or use one of the options to export in your chosen format


EXPORT



APA

Kutlu, O., Eruzun, H., & Tükek, T. (2016). YAYGIN DEĞİŞKEN İMMÜN YETERSİZLİK. Journal of Istanbul Faculty of Medicine, 79(3), 122-129. https://doi.org/https://doi.org/10.18017/iuitfd.279884


AMA

Kutlu O, Eruzun H, Tükek T. YAYGIN DEĞİŞKEN İMMÜN YETERSİZLİK. Journal of Istanbul Faculty of Medicine. 2016;79(3):122-129. https://doi.org/https://doi.org/10.18017/iuitfd.279884


ABNT

Kutlu, O.; Eruzun, H.; Tükek, T. YAYGIN DEĞİŞKEN İMMÜN YETERSİZLİK. Journal of Istanbul Faculty of Medicine, [Publisher Location], v. 79, n. 3, p. 122-129, 2016.


Chicago: Author-Date Style

Kutlu, Orkide, and Hasan Eruzun and Tufan Tükek. 2016. “YAYGIN DEĞİŞKEN İMMÜN YETERSİZLİK.” Journal of Istanbul Faculty of Medicine 79, no. 3: 122-129. https://doi.org/https://doi.org/10.18017/iuitfd.279884


Chicago: Humanities Style

Kutlu, Orkide, and Hasan Eruzun and Tufan Tükek. YAYGIN DEĞİŞKEN İMMÜN YETERSİZLİK.” Journal of Istanbul Faculty of Medicine 79, no. 3 (Aug. 2025): 122-129. https://doi.org/https://doi.org/10.18017/iuitfd.279884


Harvard: Australian Style

Kutlu, O & Eruzun, H & Tükek, T 2016, 'YAYGIN DEĞİŞKEN İMMÜN YETERSİZLİK', Journal of Istanbul Faculty of Medicine, vol. 79, no. 3, pp. 122-129, viewed 14 Aug. 2025, https://doi.org/https://doi.org/10.18017/iuitfd.279884


Harvard: Author-Date Style

Kutlu, O. and Eruzun, H. and Tükek, T. (2016) ‘YAYGIN DEĞİŞKEN İMMÜN YETERSİZLİK’, Journal of Istanbul Faculty of Medicine, 79(3), pp. 122-129. https://doi.org/https://doi.org/10.18017/iuitfd.279884 (14 Aug. 2025).


MLA

Kutlu, Orkide, and Hasan Eruzun and Tufan Tükek. YAYGIN DEĞİŞKEN İMMÜN YETERSİZLİK.” Journal of Istanbul Faculty of Medicine, vol. 79, no. 3, 2016, pp. 122-129. [Database Container], https://doi.org/https://doi.org/10.18017/iuitfd.279884


Vancouver

Kutlu O, Eruzun H, Tükek T. YAYGIN DEĞİŞKEN İMMÜN YETERSİZLİK. Journal of Istanbul Faculty of Medicine [Internet]. 14 Aug. 2025 [cited 14 Aug. 2025];79(3):122-129. Available from: https://doi.org/https://doi.org/10.18017/iuitfd.279884 doi: https://doi.org/10.18017/iuitfd.279884


ISNAD

Kutlu, Orkide - Eruzun, Hasan - Tükek, Tufan. YAYGIN DEĞİŞKEN İMMÜN YETERSİZLİK”. Journal of Istanbul Faculty of Medicine 79/3 (Aug. 2025): 122-129. https://doi.org/https://doi.org/10.18017/iuitfd.279884



Istanbul University Press aims to contribute to the dissemination of ever growing scientific knowledge through publication of high quality scientific journals and books in accordance with the international publishing standards and ethics. Istanbul University Press follows an open access, non-commercial, scholarly publishing.